Will make a lot of sense IF the process is not complicated by corruption, 
adulteration and mismanagement which is known to creep into such mega-centrally 
controlled programs.

There is a good counter-argument that Big Pharma needs to get adequate returns 
as incentive for continued research .....but, Good Lord, when one looks at the 
fine that GSB agreed to pay .. One wonders what the level of fleecing is.

jc

Pardon any Typos. This IPad does some curious auto- corrections


On Jul 6, 2012, at 4:37 AM, Gabe Menezes <[email protected]> wrote:

> http://www.independent.co.uk/news/world/asia/big-pharma-is-cut-out-by-indias-plan-to-bring-medicine-to-masses-7917944.html
> -- 
> DEV BOREM KORUM
> 
> Gabe Menezes.

Reply via email to